Clinical Trials on Glioblastoma Multiforme in Hong Kong
Total 20 results
-
Center Trials & TreatmentNo longer availableGlioblastoma Multiforme | Melanoma (Skin) | Melanoma Recurrent | Glioma of Brain | Glioblastoma by Gene Expression ProfileHong Kong, Belarus, Tajikistan, Uzbekistan
-
The University of Hong KongRecruitingRecurrent Glioblastoma | Recurrent Glioma | Poly ADP Ribose Polymerase (PARP) Inhibitor | PTEN Gene Inactivation | IDH MutationHong Kong
-
Center Trials & TreatmentWithdrawnGliosarcoma | Recurrent Glioblastoma | Anaplastic GliomasSingapore, Hong Kong
-
PfizerTerminatedAdvanced Breast Cancer (Parts 1 and 2) | Advanced Pancreatic Cancer (Part 1) | Advanced Colorectal Cancer (Part 1) | Advanced Cholangiocarcinoma (Part 1) | Advanced Glioblastoma Multiforme (Part 1)United States, Spain, Hong Kong, Belgium, Australia, France
-
Spectrum Pharmaceuticals, IncTerminatedBreast Cancer | Colorectal Cancer | Solid Tumor | Glioblastome MultiformeUnited States
-
Incheon St.Mary's HospitalNational Cancer Center, KoreaUnknownRecurrent Glioblastoma MultiformeKorea, Republic of
-
TJ Biopharma Co., Ltd.Active, not recruitingNewly Diagnosed GlioblastomaChina, Hong Kong
-
Celldex TherapeuticsCompletedGlioblastoma | Gliosarcoma | Small Cell Glioblastoma | Giant Cell Glioblastoma | Glioblastoma With Oligodendroglial ComponentUnited States, Canada, Australia, Israel, Taiwan, United Kingdom, Belgium, France, Spain, Germany, Austria, Brazil, Colombia, Czechia, Greece, Hungary, India, Italy, Mexico, Netherlands, New Zealand, Peru, Switzerland, Thailand
-
Hoffmann-La RocheCompletedGlioblastomaUnited States, United Kingdom, Belgium, Denmark, Korea, Republic of, Poland, Spain, Canada, Sweden, Russian Federation, Australia, Greece, Portugal, France, Netherlands, New Zealand, Switzerland, Germany, Hong Kong, Hungary, Israel and more
-
National Cancer Institute (NCI)NRG Oncology; Radiation Therapy Oncology GroupCompletedGlioblastoma | Gliosarcoma | Supratentorial GlioblastomaUnited States, Canada, Israel
-
AbbVieRadiation Therapy Oncology GroupCompletedGlioblastoma | GliosarcomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Colombia, Czechia, France, Germany, Hong Kong, Ireland, Israel, Italy, Korea, Republic of, Mexico, Netherlands, New Zealand, Portugal, Russian Federation, Singapor... and more
-
National Cancer Institute (NCI)RecruitingGlioblastoma | Malignant Glioma | Anaplastic Astrocytoma | Anaplastic Astrocytoma, Not Otherwise Specified | Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | Glioblastoma, Not Otherwise SpecifiedUnited States, Australia, Canada, New Zealand
-
National Cancer Institute (NCI)Active, not recruitingGlioblastoma | Malignant Glioma | Anaplastic AstrocytomaUnited States, Canada, Puerto Rico, Australia, New Zealand
-
xCuresCancer CommonsAvailableExpanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesMelanoma | Head and Neck Cancer | Glioblastoma | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Small Bowel Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Bladder Cancer | Thyroid Cancer | ERK Mutation | MAPK Gene Mutation | KRAS Activating... and other conditionsUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States, Canada
-
National Cancer Institute (NCI)RecruitingGlioblastoma | Malignant Glioma | Anaplastic Astrocytoma | Anaplastic Astrocytoma, Not Otherwise Specified | Anaplastic Ganglioglioma | Anaplastic Pleomorphic Xanthoastrocytoma | WHO Grade 3 GliomaUnited States, Puerto Rico
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedRadiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma MultiformeBrain and Central Nervous System TumorsUnited States, Canada